PURPOSE: Primary selective IgM deficiency (sIgMD) is a primary immunodeficiency with unclear pathogenesis and a low number of published cases. METHODS: We reviewed clinical and laboratory manifestations of 17 sIgMD patients. Serum IgM, IgG, and its subclasses, IgA, IgE, antibodies against tetanus toxoid, pneumococcal polysaccharides and Haemophilus influenzae type b, isohemagglutinins, and T and B lymphocyte subsets, expressions of IgM on B cells and B lymphocyte production of IgM were compared with previously reported case reports and a small series of patients, which included 81 subjects in total. RESULTS: We found that some patients in our cohort (OC) and published cases (PC) had increased IgE levels (OC 7/15; PC 21/37), decreased IgG4 levels (OC 5/14), very low titers of isohemagglutinins (OC 8/8; PC 18/21), increased transitional B cell counts (OC 8/9), decreased marginal zone B cell counts (OC 8/9), and increased 21low B cell counts (OC 7/9). Compared with the PC (20/20), only two of five OC patients showed very low or undetectable production of IgM after stimulation. A majority of the patients had normal antibody production to protein and polysaccharide antigens, basic lymphocyte subset counts, and expression of surface IgM molecules on B cells. CONCLUSIONS: Low IgM levels are associated with various immunopathological disorders; however, pathogenic mechanisms leading to decreased IgM serum level in selective IgM deficiency remain unclear. Moreover, it is difficult to elucidate how strong these associations are and if these immunopathological conditions are primary or secondary.

Charles University Prague School of Medicine and University Hospital Institute of Clinical Immunology and Allergology Hradec Kralove Czech Republic

Department of Clinical Immunology and Allergy St Anne's University Hospital in Brno Pekarska 53 65691 Brno Czech Republic

Department of Immunology Motol University Hospital Prague Czech Republic

Faculty of Medicine Masaryk University Brno Czech Republic

Transfusion and Tissue Department University Hospital Brno Brno Czech Republic

Zobrazit více v PubMed

J AAPOS. 2001 Feb;5(1):60-1 PubMed

Clin Exp Immunol. 1987 Jun;68(3):630-7 PubMed

J Exp Med. 2002 Mar 18;195(6):771-80 PubMed

Eur J Immunol. 2012 Jan;42(1):241-7 PubMed

Br Med J. 1967 Dec 9;4(5579):583-6 PubMed

Clin Immunol Immunopathol. 1988 Mar;46(3):360-7 PubMed

J Immunol. 2002 Dec 15;169(12):6686-90 PubMed

Int J Hematol. 2001 Jun;73(4):532-533 PubMed

J Clin Pathol. 1976 Sep;29(9):773-7 PubMed

Int Arch Allergy Immunol. 2009;150(3):291-8 PubMed

J Allergy Clin Immunol. 1975 Jan;55(1):35-48 PubMed

Clin Exp Immunol. 2010 Nov;162(2):271-9 PubMed

Ann Allergy. 1989 Jun;62(6):547-52 PubMed

Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1184-9 PubMed

Immunol Lett. 1982 May;4(5):253-8 PubMed

Immunol Rev. 2005 Feb;203:67-79 PubMed

Clin Immunol Immunopathol. 1982 Dec;25(3):386-94 PubMed

J Immunol. 2013 Jan 1;190(1):106-14 PubMed

Clin Immunol. 2015 Dec;161(2):96-102 PubMed

Allergol Int. 2008 Mar;57(1):99-105 PubMed

Int J Immunopathol Pharmacol. 2015 Dec;28(4):547-56 PubMed

Int J Mycobacteriol. 2016 Mar;5(1):106-10 PubMed

PLoS One. 2008 Aug 21;3(8):e3033 PubMed

Rheumatol Int. 2009 May;29(7):811-5 PubMed

Mol Immunol. 2016 Apr;72 :9-18 PubMed

J Exp Med. 2003 Dec 15;198(12):1853-62 PubMed

Scand J Immunol. 2015 Sep;82(3):254-61 PubMed

Hum Immunol. 2016 Jan;77(1):7-11 PubMed

Int Arch Allergy Immunol. 2013;161(1):91-6 PubMed

Clin Exp Immunol. 1982 Sep;49(3):670-6 PubMed

Jpn J Med. 1984 May;23(2):149-51 PubMed

Eur J Haematol. 2004 Mar;72(3):203-12 PubMed

J Microbiol Immunol Infect. 2016 Feb;49(1):150-3 PubMed

Nat Rev Immunol. 2010 Nov;10(11):778-86 PubMed

Intern Med. 1992 Jul;31(7):866-70 PubMed

J Immunol. 2012 Feb 1;188(3):939-45 PubMed

J Investig Allergol Clin Immunol. 2013;23(2):94-100 PubMed

J Immunol. 1998 May 15;160(10):4776-87 PubMed

Am J Med. 1976 Apr;60(4):486-94 PubMed

J Exp Med. 2000 Jul 17;192(2):271-80 PubMed

Am J Med Genet A. 2004 May 15;127A(1):99-100 PubMed

Autoimmunity. 2001;34(2):115-22 PubMed

J Clin Immunol. 2011 Jun;31(3):315-22 PubMed

Clin J Sport Med. 2004 Nov;14(6):357-9 PubMed

Cancer. 1982 Jan 15;49(2):234-8 PubMed

Ann Allergy Asthma Immunol. 2006 Dec;97(6):717-30 PubMed

J Immunol. 2015 Feb 15;194(4):1489-502 PubMed

J Investig Allergol Clin Immunol. 2014;24(6):442-4 PubMed

Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10089-93 PubMed

Bull World Health Organ. 1981;59(1):99-106 PubMed

Int Arch Allergy Immunol. 2009;149(3):283-8 PubMed

J Pediatr Hematol Oncol. 2011 May;33(4):e156-9 PubMed

Scand J Immunol. 1989 Oct;30(4):419-24 PubMed

J Clin Immunol. 1986 Mar;6(2):130-5 PubMed

Immunol Rev. 2016 Mar;270(1):8-19 PubMed

Turk J Pediatr. 2014 Jan-Feb;56(1):41-7 PubMed

BMJ Case Rep. 2014 Sep 01;2014:null PubMed

Eur J Pediatr. 1986 Apr;145(1-2):99-103 PubMed

J Clin Immunol. 2017 May;37(4):329-331 PubMed

Aust N Z J Med. 1978 Aug;8(4):436-8 PubMed

Am J Clin Exp Immunol. 2016 Mar 23;5(1):21-32 PubMed

Clin Rev Allergy Immunol. 2014 Apr;46(2):104-11 PubMed

Clin Dev Immunol. 2008;2008:624850 PubMed

Immunobiology. 2014 Jul;219(7):487-96 PubMed

Lung India. 2014 Jul;31(3):296-8 PubMed

Blood. 2008 Jan 1;111(1):77-85 PubMed

J Investig Allergol Clin Immunol. 2008;18(3):214-8 PubMed

Epidemiol Infect. 1993 Feb;110(1):145-60 PubMed

Lancet. 1970 Nov 21;2(7682):1061-3 PubMed

Ann Lab Med. 2013 May;33(3):208-11 PubMed

Tokai J Exp Clin Med. 1981 Jul;6(3):327-31 PubMed

Immunol Allergy Clin North Am. 2015 Nov;35(4):731-52 PubMed

J Allergy Clin Immunol. 2012 Mar;129(3):770-7 PubMed

Curr Opin Immunol. 1996 Dec;8(6):843-51 PubMed

Ann Allergy Asthma Immunol. 2007 Jul;99(1):87-92 PubMed